NCT06144606 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) Status RECRUITING Phase PHASE2
NCT03642626 MT2017-45: CAR-T Cell Therapy for Heme Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2